The purpose of this study was to investigate the implication of the ABCB1 C3435Tpolymorphism on the pharmacokinetics of ( R ) - lansoprazole , the major enantiomer , in CYP2C19 extensive metabolizers ( EMs ) and on gastroesophageal symptoms in renal transplant recipients receiving tacrolimus .